I now have a solid evidence base to give a thorough, guideline-aligned answer.
Short Answer First
No - in a 30-year-old with a normal pregnancy and no risk factors or symptoms, there is NO indication to prescribe dydrogesterone or progesterone. Routine supplementation in an uncomplicated, asymptomatic pregnancy has no proven benefit and is not recommended by any major guideline (RCOG, ESHRE, FIGO). Prescribing it would be empirical, not evidence-based.
Detailed Clinical Reasoning
When IS progesterone/dydrogesterone indicated in pregnancy?
Evidence and guidelines support progestogen use only in specific high-risk situations, not as a routine supplement:
| Indication | Evidence-Based Treatment |
|---|
| Threatened miscarriage (vaginal bleeding in early pregnancy) + prior miscarriage history | Vaginal micronized progesterone 400 mg BD until 16 weeks (RCOG 2023, ESHRE 2022) |
| Recurrent pregnancy loss (≥3 losses) with current bleeding | Vaginal progesterone or oral dydrogesterone (ESHRE 2022) |
| Short cervix (singleton pregnancy, cervical length <25 mm) | Vaginal progesterone |
| Prior spontaneous preterm birth (singleton) | 17α-hydroxyprogesterone caproate or vaginal progesterone (though recent RCTs have weakened this evidence, and the FDA withdrew approval of 17-OHPC in 2023) |
| IVF/ART luteal phase support | Progesterone supplementation until ~10-12 weeks |
What do guidelines say about normal, uncomplicated pregnancy?
From the evidence gathered:
- RCOG 2023: "Routine progesterone supplementation should be used with caution in asymptomatic women with unexplained recurrent miscarriage" - and this caution is even stronger for women with no history of miscarriage at all.
- FIGO 2023: Vaginal progesterone supplementation "is not recommended in asymptomatic women" with a history of recurrent miscarriage; this standard applies even more strictly to normal pregnancies.
- NHS / Right Decisions Scotland (updated 2026): "There is no evidence that routine progesterone supplementation for women with recurrent miscarriage in the absence of bleeding is of benefit" - again, a normal pregnancy has even less justification.
- Creasy & Resnik's Maternal-Fetal Medicine: Progesterone is critical in early pregnancy (corpus luteum function until 7-9 weeks), but in a normal pregnancy the placenta takes over seamlessly - there is no rationale to supplement an already-adequate endogenous supply.
Why the "everything is normal" finding is actually a reason NOT to prescribe
In a normal pregnancy:
- The corpus luteum produces adequate progesterone until placental take-over (~7-9 weeks)
- After that, the placenta produces rising progesterone throughout pregnancy
- There is no luteal phase deficiency, no threatened loss, no cervical shortening, no prior preterm birth
- Supplementing an already-normal progesterone milieu has no demonstrated benefit
Specific drugs you mentioned
- Dydrogesterone 10 mg: A synthetic retro-progesterone with oral bioavailability. Used in threatened/recurrent miscarriage. No indication in normal uncomplicated pregnancy.
- Progesterone 200 mg (vaginal/oral): Micronized natural progesterone. Used in specific indications listed above. No indication in normal uncomplicated pregnancy.
Bottom line
Do not prescribe either drug in the absence of a specific indication. Doing so would be:
- Not evidence-based
- Potentially harmful (data on safety of routine supplementation in normal pregnancies is not fully established)
- An unnecessary cost burden on the patient
Before prescribing progestogens in any pregnant woman, ask:
- History of ≥1 prior miscarriage?
- Current vaginal bleeding?
- Short cervix on ultrasound?
- Prior preterm birth?
- ART/IVF conception?
- Documented low progesterone level?
If the answer to all is no, the prescription is not indicated.
References: Creasy & Resnik's Maternal-Fetal Medicine (p.126); RCOG Green-top Guideline 2023; ESHRE Recurrent Pregnancy Loss Guideline 2022; FIGO Good Practice Recommendations 2023; NHS Right Decisions Scotland (updated April 2026)